Skip to main content

IDH1 Gene Mutation clinical trials at UCSF

2 in progress, 1 open to eligible people

IDH1 gene mutation is a genetic alteration that can lead to cancer. UCSF is testing a new treatment using BGB-290 and temozolomide for brain tumors. These trials are examining the side effects and the most effective dose to use in treating these tumors.

Showing trials for

Last updated: